Sandy Blackadder Primrose

Glycoscoredx Ltd. develops a novel blood test that revolutionizes how prostate cancer is diagnosed. The company is based in Newcastle upon Tyne, UK. The British company was founded in 2020 by Jennifer Munkley. Allan Brown has been the CEO of the company since 2020.

The Pirbright Institute, founded in 1914, is based in Woking, UK. The institute specializes in preventing and controlling viral diseases of livestock and those that spread from animals to people. The British company's facilities and capabilities provide opportunities for collaboration with other institutes and industries in research, data analysis, training, and access to some areas on-site. The institute offers a range of products, including positive sera, inactivated antigens, diagnostic kits, viral cultures, and live midges. The non-profit company's high containment facilities are internationally groundbreaking in design and maintenance, and they provide consultancy in architecture, engineering, and highly specialized expertise in risk and assurance. The diagnostic development team works with the world reference laboratory for foot-and-mouth disease at the Pirbright Institute and external partners to provide diagnostic products for foot-and-mouth disease (FMD), swine vesicular disease (SVD), and peste des petit ruminants (PPR).

The Pirbright Institute, founded in 1914, is based in Woking, UK. The institute specializes in preventing and controlling viral diseases of livestock and those that spread from animals to people. The British company's facilities and capabilities provide opportunities for collaboration with other institutes and industries in research, data analysis, training, and access to some areas on-site. The institute offers a range of products, including positive sera, inactivated antigens, diagnostic kits, viral cultures, and live midges. The non-profit company's high containment facilities are internationally groundbreaking in design and maintenance, and they provide consultancy in architecture, engineering, and highly specialized expertise in risk and assurance. The diagnostic development team works with the world reference laboratory for foot-and-mouth disease at the Pirbright Institute and external partners to provide diagnostic products for foot-and-mouth disease (FMD), swine vesicular disease (SVD), and peste des petit ruminants (PPR).

The Pirbright Institute, founded in 1914, is based in Woking, UK. The institute specializes in preventing and controlling viral diseases of livestock and those that spread from animals to people. The British company's facilities and capabilities provide opportunities for collaboration with other institutes and industries in research, data analysis, training, and access to some areas on-site. The institute offers a range of products, including positive sera, inactivated antigens, diagnostic kits, viral cultures, and live midges. The non-profit company's high containment facilities are internationally groundbreaking in design and maintenance, and they provide consultancy in architecture, engineering, and highly specialized expertise in risk and assurance. The diagnostic development team works with the world reference laboratory for foot-and-mouth disease at the Pirbright Institute and external partners to provide diagnostic products for foot-and-mouth disease (FMD), swine vesicular disease (SVD), and peste des petit ruminants (PPR).

The Pirbright Institute, founded in 1914, is based in Woking, UK. The institute specializes in preventing and controlling viral diseases of livestock and those that spread from animals to people. The British company's facilities and capabilities provide opportunities for collaboration with other institutes and industries in research, data analysis, training, and access to some areas on-site. The institute offers a range of products, including positive sera, inactivated antigens, diagnostic kits, viral cultures, and live midges. The non-profit company's high containment facilities are internationally groundbreaking in design and maintenance, and they provide consultancy in architecture, engineering, and highly specialized expertise in risk and assurance. The diagnostic development team works with the world reference laboratory for foot-and-mouth disease at the Pirbright Institute and external partners to provide diagnostic products for foot-and-mouth disease (FMD), swine vesicular disease (SVD), and peste des petit ruminants (PPR).

The Pirbright Institute, founded in 1914, is based in Woking, UK. The institute specializes in preventing and controlling viral diseases of livestock and those that spread from animals to people. The British company's facilities and capabilities provide opportunities for collaboration with other institutes and industries in research, data analysis, training, and access to some areas on-site. The institute offers a range of products, including positive sera, inactivated antigens, diagnostic kits, viral cultures, and live midges. The non-profit company's high containment facilities are internationally groundbreaking in design and maintenance, and they provide consultancy in architecture, engineering, and highly specialized expertise in risk and assurance. The diagnostic development team works with the world reference laboratory for foot-and-mouth disease at the Pirbright Institute and external partners to provide diagnostic products for foot-and-mouth disease (FMD), swine vesicular disease (SVD), and peste des petit ruminants (PPR).

Glycoscoredx Ltd. develops a novel blood test that revolutionizes how prostate cancer is diagnosed. The company is based in Newcastle upon Tyne, UK. The British company was founded in 2020 by Jennifer Munkley. Allan Brown has been the CEO of the company since 2020.

The Pirbright Institute, founded in 1914, is based in Woking, UK. The institute specializes in preventing and controlling viral diseases of livestock and those that spread from animals to people. The British company's facilities and capabilities provide opportunities for collaboration with other institutes and industries in research, data analysis, training, and access to some areas on-site. The institute offers a range of products, including positive sera, inactivated antigens, diagnostic kits, viral cultures, and live midges. The non-profit company's high containment facilities are internationally groundbreaking in design and maintenance, and they provide consultancy in architecture, engineering, and highly specialized expertise in risk and assurance. The diagnostic development team works with the world reference laboratory for foot-and-mouth disease at the Pirbright Institute and external partners to provide diagnostic products for foot-and-mouth disease (FMD), swine vesicular disease (SVD), and peste des petit ruminants (PPR).

The Pirbright Institute, founded in 1914, is based in Woking, UK. The institute specializes in preventing and controlling viral diseases of livestock and those that spread from animals to people. The British company's facilities and capabilities provide opportunities for collaboration with other institutes and industries in research, data analysis, training, and access to some areas on-site. The institute offers a range of products, including positive sera, inactivated antigens, diagnostic kits, viral cultures, and live midges. The non-profit company's high containment facilities are internationally groundbreaking in design and maintenance, and they provide consultancy in architecture, engineering, and highly specialized expertise in risk and assurance. The diagnostic development team works with the world reference laboratory for foot-and-mouth disease at the Pirbright Institute and external partners to provide diagnostic products for foot-and-mouth disease (FMD), swine vesicular disease (SVD), and peste des petit ruminants (PPR).

The Pirbright Institute, founded in 1914, is based in Woking, UK. The institute specializes in preventing and controlling viral diseases of livestock and those that spread from animals to people. The British company's facilities and capabilities provide opportunities for collaboration with other institutes and industries in research, data analysis, training, and access to some areas on-site. The institute offers a range of products, including positive sera, inactivated antigens, diagnostic kits, viral cultures, and live midges. The non-profit company's high containment facilities are internationally groundbreaking in design and maintenance, and they provide consultancy in architecture, engineering, and highly specialized expertise in risk and assurance. The diagnostic development team works with the world reference laboratory for foot-and-mouth disease at the Pirbright Institute and external partners to provide diagnostic products for foot-and-mouth disease (FMD), swine vesicular disease (SVD), and peste des petit ruminants (PPR).

The Pirbright Institute, founded in 1914, is based in Woking, UK. The institute specializes in preventing and controlling viral diseases of livestock and those that spread from animals to people. The British company's facilities and capabilities provide opportunities for collaboration with other institutes and industries in research, data analysis, training, and access to some areas on-site. The institute offers a range of products, including positive sera, inactivated antigens, diagnostic kits, viral cultures, and live midges. The non-profit company's high containment facilities are internationally groundbreaking in design and maintenance, and they provide consultancy in architecture, engineering, and highly specialized expertise in risk and assurance. The diagnostic development team works with the world reference laboratory for foot-and-mouth disease at the Pirbright Institute and external partners to provide diagnostic products for foot-and-mouth disease (FMD), swine vesicular disease (SVD), and peste des petit ruminants (PPR).

Arquer Diagnostics Ltd. develops proprietary diagnostic immunoassays for the detection of prostate and bladder cancer using urine samples. Its develops non-invasive, urine-based ELISA and Point-of Care tests meet the increased demand for cost-effective healthcare technologies that not only enhance patient care but help to reduce overall healthcare costs by improving patient outcomes. The firm will commercialise ELISA and point-of-care urine tests for prostate and bladder cancer for use in the urology clinic, hospital lab and the GP’s surgery. The company was founded by David Nicholas Miller-Jones and William Dawson in 2007 and is headquartered in Sunderland, the United Kingdom.

The Pirbright Institute, founded in 1914, is based in Woking, UK. The institute specializes in preventing and controlling viral diseases of livestock and those that spread from animals to people. The British company's facilities and capabilities provide opportunities for collaboration with other institutes and industries in research, data analysis, training, and access to some areas on-site. The institute offers a range of products, including positive sera, inactivated antigens, diagnostic kits, viral cultures, and live midges. The non-profit company's high containment facilities are internationally groundbreaking in design and maintenance, and they provide consultancy in architecture, engineering, and highly specialized expertise in risk and assurance. The diagnostic development team works with the world reference laboratory for foot-and-mouth disease at the Pirbright Institute and external partners to provide diagnostic products for foot-and-mouth disease (FMD), swine vesicular disease (SVD), and peste des petit ruminants (PPR).

The Pirbright Institute, founded in 1914, is based in Woking, UK. The institute specializes in preventing and controlling viral diseases of livestock and those that spread from animals to people. The British company's facilities and capabilities provide opportunities for collaboration with other institutes and industries in research, data analysis, training, and access to some areas on-site. The institute offers a range of products, including positive sera, inactivated antigens, diagnostic kits, viral cultures, and live midges. The non-profit company's high containment facilities are internationally groundbreaking in design and maintenance, and they provide consultancy in architecture, engineering, and highly specialized expertise in risk and assurance. The diagnostic development team works with the world reference laboratory for foot-and-mouth disease at the Pirbright Institute and external partners to provide diagnostic products for foot-and-mouth disease (FMD), swine vesicular disease (SVD), and peste des petit ruminants (PPR).

Glycoscoredx Ltd. develops a novel blood test that revolutionizes how prostate cancer is diagnosed. The company is based in Newcastle upon Tyne, UK. The British company was founded in 2020 by Jennifer Munkley. Allan Brown has been the CEO of the company since 2020.

The Pirbright Institute, founded in 1914, is based in Woking, UK. The institute specializes in preventing and controlling viral diseases of livestock and those that spread from animals to people. The British company's facilities and capabilities provide opportunities for collaboration with other institutes and industries in research, data analysis, training, and access to some areas on-site. The institute offers a range of products, including positive sera, inactivated antigens, diagnostic kits, viral cultures, and live midges. The non-profit company's high containment facilities are internationally groundbreaking in design and maintenance, and they provide consultancy in architecture, engineering, and highly specialized expertise in risk and assurance. The diagnostic development team works with the world reference laboratory for foot-and-mouth disease at the Pirbright Institute and external partners to provide diagnostic products for foot-and-mouth disease (FMD), swine vesicular disease (SVD), and peste des petit ruminants (PPR).

Arquer Diagnostics Ltd. develops proprietary diagnostic immunoassays for the detection of prostate and bladder cancer using urine samples. Its develops non-invasive, urine-based ELISA and Point-of Care tests meet the increased demand for cost-effective healthcare technologies that not only enhance patient care but help to reduce overall healthcare costs by improving patient outcomes. The firm will commercialise ELISA and point-of-care urine tests for prostate and bladder cancer for use in the urology clinic, hospital lab and the GP’s surgery. The company was founded by David Nicholas Miller-Jones and William Dawson in 2007 and is headquartered in Sunderland, the United Kingdom.

The Pirbright Institute, founded in 1914, is based in Woking, UK. The institute specializes in preventing and controlling viral diseases of livestock and those that spread from animals to people. The British company's facilities and capabilities provide opportunities for collaboration with other institutes and industries in research, data analysis, training, and access to some areas on-site. The institute offers a range of products, including positive sera, inactivated antigens, diagnostic kits, viral cultures, and live midges. The non-profit company's high containment facilities are internationally groundbreaking in design and maintenance, and they provide consultancy in architecture, engineering, and highly specialized expertise in risk and assurance. The diagnostic development team works with the world reference laboratory for foot-and-mouth disease at the Pirbright Institute and external partners to provide diagnostic products for foot-and-mouth disease (FMD), swine vesicular disease (SVD), and peste des petit ruminants (PPR).